These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38992718)

  • 1. miPEP31 alleviates Ang II-induced hypertension in mice by occupying Cebpα binding sites in the pri-miR-31 promoter.
    Li X; Zhou H; Lu P; Fang Z; Shi G; Tong X; Chen W; Jiang G; Zhang P; Tian J; Li Q
    Cardiovasc Diabetol; 2024 Jul; 23(1):249. PubMed ID: 38992718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-31 Regulates Immunosuppression in Ang II (Angiotensin II)-induced Hypertension by Targeting Ppp6C (Protein Phosphatase 6c).
    Li X; Cai W; Xi W; Sun W; Shen W; Wei T; Chen X; Sun L; Zhou H; Sun Y; Chen W; Gao P; Wang H; Li Q
    Hypertension; 2019 May; 73(5):e14-e24. PubMed ID: 30929511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide encoded by pri-miRNA-31 represses autoimmunity by promoting T
    Zhou H; Lou F; Bai J; Sun Y; Cai W; Sun L; Xu Z; Liu Z; Zhang L; Yin Q; Zhang J; Gao Y; Wang Z; Niu L; Cai X; Deng S; Wang H; Xia L; Ginhoux F; Li Q; Wang H
    EMBO Rep; 2022 May; 23(5):e53475. PubMed ID: 35343645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
    Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
    FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopause and FOXP3
    Pollow DP; Uhlorn JA; Sylvester MA; Romero-Aleshire MJ; Uhrlaub JL; Lindsey ML; Nikolich-Zugich J; Brooks HL
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H415-H423. PubMed ID: 31099612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T-Cell Legumain Deficiency Attenuates Hypertensive Damage via Preservation of TRAF6.
    He Y; Zou P; Lu J; Lu Y; Yuan S; Zheng X; Liu J; Zeng C; Liu L; Tang L; Fang Z; Hu X; Liu Q; Zhou S
    Circ Res; 2024 Jan; 134(1):9-29. PubMed ID: 38047378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-431-5p Knockdown Protects Against Angiotensin II-Induced Hypertension and Vascular Injury.
    Huo KG; Richer C; Berillo O; Mahjoub N; Fraulob-Aquino JC; Barhoumi T; Ouerd S; Coelho SC; Sinnett D; Paradis P; Schiffrin EL
    Hypertension; 2019 May; 73(5):1007-1017. PubMed ID: 30929512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-532-5p-programmed cell death protein 4 (PDCD4) axis regulates angiotensin II-induced human umbilical vein endothelial cell apoptosis and proliferation.
    Wang Y; Gao C; Zhou K; Liu W; Zhang Y; Zhao Y
    Microvasc Res; 2021 Nov; 138():104195. PubMed ID: 34116070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Iulita MF; Duchemin S; Vallerand D; Barhoumi T; Alvarez F; Istomine R; Laurent C; Youwakim J; Paradis P; Arbour N; Piccirillo CA; Schiffrin EL; Girouard H
    J Am Heart Assoc; 2019 Jan; 8(1):e009372. PubMed ID: 30572753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin Protects Against Hypertensive Renal Injury by Attenuating Apoptosis: An Integrated Approach Using Network Pharmacology and RNA Sequencing.
    Zhang XL; Li JP; Wu MZ; Wu JK; He SY; Lu Y; Ding QH; Wen Y; Long LZ; Fu CG; Farman A; Shen AL; Peng J
    J Cardiovasc Pharmacol; 2024 Sep; 84(3):370-382. PubMed ID: 39027976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH; Ruan CC; Ge Q; Ma Y; Xu JZ; Zhang ZB; Lin JR; Chen DR; Zhu DL; Gao PJ
    Circ Res; 2018 Mar; 122(7):970-983. PubMed ID: 29437833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice.
    Ye J; Que B; Huang Y; Lin Y; Chen J; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Wang Z; Hu H; Xu Y; Shi L; Ye D; Liu J; Jiang H; Wan J; Ji Q
    Cardiovasc Res; 2019 May; 115(6):1102-1113. PubMed ID: 30395167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.
    Cheng Y; Wang D; Wang F; Liu J; Huang B; Baker MA; Yin J; Wu R; Liu X; Regner KR; Usa K; Liu Y; Zhang C; Dong L; Geurts AM; Wang N; Miller SS; He Y; Liang M
    J Am Soc Nephrol; 2020 Jul; 31(7):1539-1554. PubMed ID: 32487559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG12 alleviates hypertensive vascular endothelial injury through miR-25-3p/SIRT6 pathway.
    Qian W; Zheng ZQ; Nie JG; Liu LJ; Meng XZ; Sun H; Xiao FM; Kang T
    J Leukoc Biol; 2021 Oct; 110(4):651-661. PubMed ID: 33464650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-Cell-Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension.
    Nosalski R; Siedlinski M; Denby L; McGinnigle E; Nowak M; Cat AND; Medina-Ruiz L; Cantini M; Skiba D; Wilk G; Osmenda G; Rodor J; Salmeron-Sanchez M; Graham G; Maffia P; Graham D; Baker AH; Guzik TJ
    Circ Res; 2020 Apr; 126(8):988-1003. PubMed ID: 32065054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.
    Barhoumi T; Kasal DA; Li MW; Shbat L; Laurant P; Neves MF; Paradis P; Schiffrin EL
    Hypertension; 2011 Mar; 57(3):469-76. PubMed ID: 21263125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.
    Mian MO; Barhoumi T; Briet M; Paradis P; Schiffrin EL
    J Hypertens; 2016 Jan; 34(1):97-108. PubMed ID: 26630215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine receptor CX
    Ahadzadeh E; Rosendahl A; Czesla D; Steffens P; Prüßner L; Meyer-Schwesinger C; Wanner N; Paust HJ; Huber TB; Stahl RAK; Wiech T; Kurts C; Seniuk A; Ehmke H; Wenzel UO
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1526-F1535. PubMed ID: 30207169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
    Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.